Švedska - švedščina - Läkemedelsverket (Medical Products Agency)

cc pharma nordic aps - bosentanmonohydrat - filmdragerad tablett - 62,5 mg - bosentanmonohydrat 64,541 mg aktiv substans

Evropska unija - švedščina - EMA (European Medicines Agency)

laboratorios lesvi s.l. - dimetylfumarat - multipel skleros, skovvis förlöpande - immunsuppressiva - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Evropska unija - švedščina - EMA (European Medicines Agency)

novartis europharm limited - asciminib hydrochloride - leukemi, myelogen, kronisk, bcr-abl positiv - antineoplastiska medel - scemblix is indicated for the treatment of adult patients with philadelphia chromosome positive chronic myeloid leukaemia in chronic phase (ph+ cml cp) previously treated with two or more tyrosine kinase inhibitors (see section 5.

Evropska unija - švedščina - EMA (European Medicines Agency)

accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - diabetes mellitus, typ 2 - läkemedel som används vid diabetes - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. - , trippel kombinationsterapi) som ett komplement till kost och motion hos patienter bristfälligt kontrollerad på deras maximal tolererad dos av metformin och en sulphonylurea. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Evropska unija - švedščina - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - teriparatid - osteoporosis; osteoporosis, postmenopausal - calciumhomeostas - teriparatide sun is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.

Švedska - švedščina - Läkemedelsverket (Medical Products Agency)

renapharma ab - kolekalciferol - kapsel, mjuk - 2000 ie - sorbitol hjälpämne; glycerol hjälpämne; kolekalciferol 50 mikrog aktiv substans

Švedska - švedščina - Läkemedelsverket (Medical Products Agency)

aco hud nordic ab - aluminiumacetotartrat - gel - 10 mg/g - aluminiumacetotartrat 10 mg aktiv substans; etanol, vattenfri hjälpämne - medel vid sår- och brännskador

Švedska - švedščina - Läkemedelsverket (Medical Products Agency)

aco hud nordic ab - aluminiumacetotartrat - kutan lösning - 10 mg/ml - aluminiumacetotartrat 10 mg aktiv substans; etanol, vattenfri hjälpämne - medel vid sår- och brännskador

Švedska - švedščina - Läkemedelsverket (Medical Products Agency)

aco hud nordic ab - aluminiumacetotartrat - kutan lösning - 10 mg/ml - aluminiumacetotartrat 10 mg aktiv substans - medel vid sår- och brännskador

Švedska - švedščina - Läkemedelsverket (Medical Products Agency)

actavis group hf. - aluminiumhydroxid-magnesiumkarbonat - tuggtablett - 1100 mg - aluminiumhydroxid-magnesiumkarbonat 1100 mg aktiv substans; sorbitol hjälpämne - kalcium- och magnesiumsalter